This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Parrella, P. Articles by Fazio, V. M. Search for Related Content PubMed PubMed Citation Articles by Parrella, P. Articles by Fazio, V. M.

Nonrandom Distribution of Aberrant Promoter Methylation of Cancer-Related Genes in Sporadic Breast Tumors

¹ Laboratory of Gene Therapy and Oncology, Istituto di Ricovero e Cura a Carattere Scientifico "Casa Sollievo della Sofferenza," San Giovanni Rotondo (FG), Italy; ² Laboratory of Molecular Medicine and Biotechnology, ³ Department of Pathology, and ⁴ Breast Unit, Department of Surgery, University "Campus BioMedico," Rome, Italy; ⁵ Department of Pathology "L. Armanni" II University of Naples, Naples, Italy; ⁶ Neurobiology and Molecular Medicine Institute, Molecular Medicine Section, Consiglio Nazionale delle Ricerche, Rome, Italy; ⁷ Department of Pathology, The Johns Hopkins University School of Medicine, Baltimore, Maryland; and ⁸ Clinical Experimental Oncology Laboratory and Department "Donna," National Cancer Institute, Bari, Italy

ABSTRACT

Purpose: In an effort to additionally determine the global patterns of CpG island hypermethylation in sporadic breast cancer, we searched for aberrant promoter methylation at 10 gene loci in 54 primary breast cancer and 10 breast benign lesions.

Experimental Design: Genomic DNA sodium bisulfate converted from benign and malignant tissues was used as template in methyl-specific PCR for BRCA1, p16, ESR1, GSTP1, TRß1, RARß2, HIC1, APC, CCND2, and CDH1 genes.

Results: The majority of the breast cancer (85%) showed aberrant methylation in at least 1 of the loci tested with half of them displaying 3 or more methylated genes. The highest frequency of aberrant promoter methylation was found for HIC1 (48%) followed by ESR1 (46%), and CDH1 (39%). Similar methylation frequencies were detected for breast benign lesions with the exception of the CDH1 gene (P = 0.02). The analysis of methylation distribution indicates a statistically significant association between methylation of the ESR1 promoter, and methylation at CDH1, TRß1, GSTP1, and CCND2 loci (P < 0.03). Methylated status of the BRCA1 promoter was inversely correlated with methylation at the RARß2 locus (P < 0.03).

Conclusions: Our results suggest a nonrandom distribution for promoter hypermethylation in sporadic breast cancer, with tumor subsets characterized by aberrant methylation of specific cancer-related genes. These breast cancer subgroups may represent separate biological entities with potential differences in sensitivity to therapy, occurrence of metastasis, and overall prognosis.

This article has been cited by other articles:

				S. N. Vasilatos, G. Broadwater, W. T. Barry, J. C. Baker Jr., S. Lem, E. C. Dietze, G. R. Bean, A. D. Bryson, P. G. Pilie, V. Goldenberg, et al. CpG Island Tumor Suppressor Promoter Methylation in Non-BRCA-Associated Early Mammary Carcinogenesis Cancer Epidemiol. Biomarkers Prev., March 1, 2009; 18(3): 901 - 914. [Abstract] [Full Text] [PDF]

				C. Bernal, F. Aguayo, C. Villarroel, M. Vargas, I. Diaz, F. J. Ossandon, E. Santibanez, M. Palma, E. Aravena, C. Barrientos, et al. Reprimo as a Potential Biomarker for Early Detection in Gastric Cancer Clin. Cancer Res., October 1, 2008; 14(19): 6264 - 6269. [Abstract] [Full Text] [PDF]

				N. Dumont, M. B. Wilson, Y. G. Crawford, P. A. Reynolds, M. Sigaroudinia, and T. D. Tlsty Sustained induction of epithelial to mesenchymal transition activates DNA methylation of genes silenced in basal-like breast cancers PNAS, September 30, 2008; 105(39): 14867 - 14872. [Abstract] [Full Text] [PDF]

				G. R. Bean, A. D. Bryson, P. G. Pilie, V. Goldenberg, J. C. Baker Jr., C. Ibarra, D. M.U. Brander, C. Paisie, N. R. Case, M. Gauthier, et al. Morphologically Normal-Appearing Mammary Epithelial Cells Obtained from High-Risk Women Exhibit Methylation Silencing of INK4a/ARF Clin. Cancer Res., November 15, 2007; 13(22): 6834 - 6841. [Abstract] [Full Text] [PDF]

				D. M. Euhus, D. Bu, R. Ashfaq, X.-J. Xie, A. Bian, A. M. Leitch, and C. M. Lewis Atypia and DNA Methylation in Nipple Duct Lavage in Relation to Predicted Breast Cancer Risk Cancer Epidemiol. Biomarkers Prev., September 1, 2007; 16(9): 1812 - 1821. [Abstract] [Full Text] [PDF]

				M. D. Williams, N. Chakravarti, M. S. Kies, S.-I. Maruya, J. N. Myers, J. C. Haviland, R. S. Weber, R. Lotan, and A. K. El-Naggar Implications of Methylation Patterns of Cancer Genes in Salivary Gland Tumors Clin. Cancer Res., December 15, 2006; 12(24): 7353 - 7358. [Abstract] [Full Text] [PDF]

				Q. Feng and N. B. Kiviat RESPONSE: Re: Detection of Hypermethylated Genes in Women With and Without Cervical Neoplasia J Natl Cancer Inst, October 19, 2005; 97(20): 1548 - 1549. [Full Text] [PDF]

				M. W.Y. Chan, S. H. Wei, P. Wen, Z. Wang, D. E. Matei, J. C. Liu, S. Liyanarachchi, R. Brown, K. P. Nephew, P. S. Yan, et al. Hypermethylation of 18S and 28S Ribosomal DNAs Predicts Progression-Free Survival in Patients with Ovarian Cancer Clin. Cancer Res., October 15, 2005; 11(20): 7376 - 7383. [Abstract] [Full Text] [PDF]